Type 2 & other diabetes

Mediating role of inflammatory biomarkers in the causal effect of body composition on glycaemic traits and type 2 diabetes

Diabetes Obes MetabPublished Retrospective observational study and Mendelian randomisation study

Authors' conclusion

Our findings suggest that different body compositions have differential influences on glycaemic traits and type 2 diabetes through distinct inflammatory biomarkers. The findings may be helpful in tailoring management of body composition based on inflammatory biomarkers with different glycaemic statuses.

Study context

Population
Chinese children and adolescents aged 6–18 years with DXA body composition (observational); Mendelian randomization (MR) on summary statistics from UK Biobank, deCODE2021, MAGIC and other large consortiumsobservational cohort
Participants
4,717 children
Outcome
Mediation by inflammatory biomarkers of body composition effects on glycaemic traits and T2D
Methodological detailsmediation analysis
  • Mediation analysis

Main finding

As reported in the abstract

Observational: Parathyroid hormone (PTH) and osteocalcin played significant roles in the association of fat mass and fat-free mass with fasting glucose, fasting insulin and homeostasis model assessment of insulin resistance (HOMA-IR)
all p < 0.05
MR: fat-free mass on T2D via FGF23, indirect effect OR
1.14 (1.01-1.28) (95% CI)
MR: fat-free mass on T2D via adiponectin, OR
0.85 (0.77-0.93) (95% CI)
MR: leptin mediating fat mass effect on fasting glucose, indirect effect β
−0.05 (−0.07, −0.02) (95% CI)
MR: leptin mediating fat-free mass effect on fasting glucose, β
0.03 (0.01, 0.04) (95% CI)

Observational data: associations, not effects.

Original publication

Mediating role of inflammatory biomarkers in the causal effect of body composition on glycaemic traits and type 2 diabetes. Diabetes Obes Metab. Published 4 September 2024. doi:10.1111/dom.15923

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.